An Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke [ 2014 - 2018 ]

Also known as: Assessment oF FluoxetINe In sTroke recoverY (AFFINITY)

Research Grant

[Cite as]

Researchers: Prof Graeme Hankey (Principal investigator) ,  A/Pr Christopher Etherton-Beer A/Pr Laurent Billot A/Pr Maree Hackett Dr Andrew Ford
View all 10 related researchers

Brief description Stroke is one of the top three causes of disability. Treatments that improve recovery after stroke are lacking. We reviewed the world literature and found a number of very small studies which, together, suggest that the antidepressant drug, fluoxetine, may improve the recovery in stroke patients. AFFINITY is a large trial in 1600 Australians and New Zealanders with stroke which aims to find out whether taking fluoxetine for 6 months after a stroke improves recovery compared to a placebo.

Funding Amount $AUD 2,306,367.21

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]